| RSLCX | RSLDX | RSLCX / RSLDX | |
| Total Expense Ratio | 1.30 | 0.80 | 163% |
| Annual Report Gross Expense Ratio | 1.30 | 0.80 | 163% |
| Fund Existence | 23 years | 10 years | - |
| Gain YTD | 12.690 | 13.225 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 83.3B | 83.3B | 100% |
| Annual Yield % from dividends | 0.38 | 0.76 | 49% |
| Returns for 1 year | 6.30 | 6.84 | 92% |
| Returns for 3 years | 29.30 | 31.03 | 94% |
| Returns for 5 years | 0.38 | 3.56 | 11% |
| Returns for 10 years | 56.37 | 65.95 | 85% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GHYG | 45.96 | 0.13 | +0.28% |
| iShares US & Intl High Yield Corp Bd ETF | |||
| QMMY | 24.85 | 0.06 | +0.22% |
| FT Vest Nasdaq-100 Mod Buffr ETF - May | |||
| RSPE | 29.33 | N/A | +0.01% |
| Invesco ESG S&P 500 Equal Weight ETF | |||
| VOE | 175.69 | -0.59 | -0.33% |
| Vanguard Mid-Cap Value ETF | |||
| LABU | 147.82 | -5.53 | -3.61% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||